The oral contraceptive is one of the most widely taken medications in the healthy population.
The clinically important side-effects are venous and arterial thrombosis. Accurate estimates …

Based on epidemiologic data, women who take oral contraceptives seem to have an
increased risk of developing thromboembolic disease. In order to explain this association …

PIP: The results of 3 British and 1 American investigation of the risk of thromboembolism
among women using oral contraceptives are reviewed. 1 British study conducted among …

The use of oral contraceptives is associated with altered plasma concentrations of many
components of the coagulation and fibrinolysis system, increased plasma levels of markers …

The increased risk of venous thrombosis in women taking oral contraceptives (OCs) has
been recognized since the early 1960s. Finding hematologic links between OC use and …

Oral contraceptives have been linked to an increased incidence of thrombovascular
disease. This may be mediated by their effects on the haemostatic system. An increase in …

933 ietters to the Editor more, in publications appearing in the same issue of the‡ ournal as
hluft€ s sceptical commentary evidence is presented from alternative assays for increased …

Oral contraceptives increase the natural incidence of venous thrombosis of 1-2/10,000
women per year 3-to 4-fold. Recent studies have shown that desogestrel or gestodene …

PIP: Low-dose oral contraceptives when tested for vascular or thrombotic effects not only
show no risk of venous thromboembolic disease, but this method could possibly reduce the …

The relationship between oral contraceptive usage and thromboembolism is controversial.
Since thromboembolism is often undiagnosed, both clinically and at routine autopsy, most …